JinA Lee, CEO & CSO of Bayer Korea and an honorable mentor of the Women in Korea (WIR) program by the Korean-German Chamber of Commerce and Industry (KGCCI), recently shared deep insights on Bayer Korea’s 70-year history, its vision for innovation, and the company’s evolving organizational culture and leadership in an interview with Fortune Korea.
She emphasized that accelerating innovation in the healthcare and agricultural sectors is essential to meeting the changing needs of Korean society. She added that the DSO model introduced last year has significantly improved decision-making speed and execution, providing a strong foundation for delivering new drugs and innovative solutions to the Korean market with greater agility.
For the full interview, please check out the link.